Streetbeat News

Analyst Ratings

ORA

Barclays analyst Derek Podhaizer maintains an Equal-Weight rating on Ormat Technologies (ORA) and lowers the price target from $82 to $75.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:37 pm

MPW

NSA

UNIT

Wall Street's most accurate analysts recommend selling three high-dividend yielding real estate stocks: Uniti Group Inc. (UNIT), Medical Properties Trust, Inc. (MPW), and National Storage Affiliates Trust (NSA). These recommendations come amidst market turbulence, with each stock facing specific challenges such as weaker-than-expected sales or plans to recover uncollected rents.

Portfolio Pulse from Avi Kapoor

February 05, 2024 | 1:36 pm

MPC

Barclays analyst Theresa Chen maintains an Overweight rating on Marathon Petroleum (MPC) and raises the price target from $163 to $168.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:36 pm

LYB

Barclays analyst Michael Leithead maintains an Equal-Weight rating on LyondellBasell Industries (LYB) and lowers the price target from $102 to $98.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:34 pm

SDHC

Wedbush analyst Jay McCanless initiates coverage on Smith Douglas Homes (SDHC) with a Neutral rating and a price target of $23.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:29 pm

DOV

Seaport Global analyst Walt Liptak upgraded Dover (NYSE:DOV) from Neutral to Buy and set a price target of $190.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:26 pm

ADUS

William Blair analyst Jared Haase has initiated coverage on Addus HomeCare (NASDAQ:ADUS) with an Outperform rating, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:22 pm

RSKD

DA Davidson analyst Gil Luria initiates coverage on Riskified (NYSE:RSKD) with a Neutral rating and a price target of $5.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:16 pm

CI

Cigna Corporation (NYSE:CI) reported Q4 2023 sales of $51.15 billion, a 12% increase Y/Y, surpassing consensus estimates. Adjusted EPS was $6.79, beating Wall Street's expectation of $6.53. The company also announced a 14% increase in its quarterly dividend to $1.40 per share and provided a strong FY 2024 revenue outlook of at least $235 billion with an adjusted EPS of at least $28.25. Following the report, Cigna's shares rose 5.4%. Analysts from Cantor Fitzgerald and RBC Capital raised their price targets on Cigna, upgrading the stock to Overweight and Outperform, respectively.

Portfolio Pulse from Avi Kapoor

February 05, 2024 | 1:15 pm

SDHC

JP Morgan analyst Michael Rehaut initiates coverage on Smith Douglas Homes (SDHC) with an Overweight rating and a price target of $31.5.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:14 pm